Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.
Rizvi, Hira
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 03 2018 - 633-641 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.2017.75.3384 doi
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
High-Throughput Nucleotide Sequencing--methods
Humans
Lung Neoplasms--drug therapy
Mutation
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Tumor Burden
Exome Sequencing
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 03 2018 - 633-641 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1527-7755
10.1200/JCO.2017.75.3384 doi
B7-H1 Antigen--antagonists & inhibitors
Carcinoma, Non-Small-Cell Lung--drug therapy
High-Throughput Nucleotide Sequencing--methods
Humans
Lung Neoplasms--drug therapy
Mutation
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Tumor Burden
Exome Sequencing